SCHEDULE: Empery Asset Management Discloses Lantern Pharma Stake

Empery Asset Management, LP and Ryan M. Lane have filed a Schedule 13G, reporting beneficial ownership of 9.99% of Lantern Pharma Inc.'s common stock, including shares issuable from warrants.

Summary

• Empery Asset Management, LP and Ryan M. Lane have jointly filed a Schedule 13G, indicating their beneficial ownership of Lantern Pharma Inc. common stock.
• The total beneficial ownership is reported as 1,322,551 shares, representing 9.99% of the class of securities.
• This ownership includes 479,882 shares of common stock issuable upon the exercise of warrants.
• A 'Blocker' provision limits the exercise of warrants to prevent ownership exceeding 9.99% of outstanding common stock.
• The filing is dated June 30, 2026, with the statement signed on August 4, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but controlled stake in Lantern Pharma, without immediate strong buy or sell signals.

Positives

• Empery Asset Management has taken a significant stake, reaching the 9.99% ownership threshold, which can signal confidence in the company's future prospects.
• The inclusion of shares issuable from warrants suggests a potential for increased ownership if market conditions allow and the 'Blocker' is no longer a constraint.

Negatives

• The 'Blocker' provision explicitly limits the ability to exercise all warrants, capping ownership at 9.99% and indicating potential regulatory or contractual constraints on further investment.
• The filing does not provide specific details on the acquisition cost or the strategy behind acquiring this stake, leaving investor intent open to interpretation.

Risks

• The 'Blocker' provision restricts the full exercise of warrants, meaning that despite holding warrants for more shares, the actual ownership percentage is capped.
• The reliance on warrants for a portion of the ownership means the value and potential ownership are tied to the exercise price and the company's stock performance.

Future Outlook

The filing does not contain forward-looking statements or specific guidance. The future outlook is indirectly influenced by the 'Blocker' provision, which limits the reporting persons' ability to increase their stake beyond 9.99% through warrant exercise.

Management Comments

• Empery Asset Management, LP and Ryan M. Lane acknowledge that each shall be responsible for the timely filing of amendments and the completeness and accuracy of the information concerning themselves, but not for others, except to the extent they know or have reason to believe such information is inaccurate.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. Reaching the 9.99% threshold often triggers such filings and can be a precursor to further strategic actions or simply a disclosure of a substantial investment position.

Stakeholder Impact

• Shareholders: The filing indicates a significant institutional investor has taken a substantial position, which could influence market perception and potentially lead to increased trading volume or volatility.
• Management: The 9.99% ownership threshold may signal increased scrutiny or potential influence from Empery Asset Management on corporate strategy or governance.

Next Steps

• Empery Asset Management, LP and Ryan M. Lane will file any subsequent amendments to this Schedule 13G statement as required.
• The reporting persons will continue to hold their stake in Lantern Pharma Inc., subject to the 'Blocker' provision.

Key Dates

Keywords

Lantern Pharma, Schedule 13G, Empery Asset Management, Ryan M. Lane, Beneficial Ownership, Warrants, Blocker Provision, Investment Management